Structure

Physi-Chem Properties

Molecular Weight:  294.11
Volume:  284.522
LogP:  1.244
LogD:  1.242
LogS:  -3.113
# Rotatable Bonds:  0
TPSA:  107.22
# H-Bond Aceptor:  6
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.542
Synthetic Accessibility Score:  4.257
Fsp3:  0.533
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.185
MDCK Permeability:  1.1255539902776945e-05
Pgp-inhibitor:  0.002
Pgp-substrate:  0.931
Human Intestinal Absorption (HIA):  0.022
20% Bioavailability (F20%):  0.008
30% Bioavailability (F30%):  0.575

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.323
Plasma Protein Binding (PPB):  77.73312377929688%
Volume Distribution (VD):  0.788
Pgp-substrate:  18.840747833251953%

ADMET: Metabolism

CYP1A2-inhibitor:  0.172
CYP1A2-substrate:  0.469
CYP2C19-inhibitor:  0.023
CYP2C19-substrate:  0.524
CYP2C9-inhibitor:  0.014
CYP2C9-substrate:  0.243
CYP2D6-inhibitor:  0.019
CYP2D6-substrate:  0.171
CYP3A4-inhibitor:  0.244
CYP3A4-substrate:  0.204

ADMET: Excretion

Clearance (CL):  13.382
Half-life (T1/2):  0.264

ADMET: Toxicity

hERG Blockers:  0.037
Human Hepatotoxicity (H-HT):  0.273
Drug-inuced Liver Injury (DILI):  0.529
AMES Toxicity:  0.073
Rat Oral Acute Toxicity:  0.062
Maximum Recommended Daily Dose:  0.09
Skin Sensitization:  0.431
Carcinogencity:  0.312
Eye Corrosion:  0.004
Eye Irritation:  0.028
Respiratory Toxicity:  0.935

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC175192

Natural Product ID:  NPC175192
Common Name*:   Monodictysin A
IUPAC Name:   (1S,3S,4S,4aS,9aS)-1,3,4,8-tetrahydroxy-4a,6-dimethyl-2,3,4,9a-tetrahydro-1H-xanthen-9-one
Synonyms:  
Standard InCHIKey:  UMAJXYGKDGKWLP-AOZIVVCUSA-N
Standard InCHI:  InChI=1S/C15H18O6/c1-6-3-7(16)11-10(4-6)21-15(2)12(13(11)19)8(17)5-9(18)14(15)20/h3-4,8-9,12,14,16-18,20H,5H2,1-2H3/t8-,9-,12+,14-,15-/m0/s1
SMILES:  Cc1cc(O)c2c(c1)O[C@]1([C@@H](C2=O)[C@@H](O)C[C@@H]([C@@H]1O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL373944
PubChem CID:   16114918
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5623 Monodictys putredinis Species n.a. Eukaryota n.a. n.a. n.a. PMID[17291041]
NPO5623 Monodictys putredinis Species n.a. Eukaryota n.a. n.a. n.a. PMID[18939864]
NPO5623 Monodictys putredinis Species n.a. Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT440 Individual Protein Quinone oxidoreductase Mus musculus IC50 > 400000.0 nM PMID[554175]
NPT30 Individual Protein Cyclooxygenase-1 Homo sapiens Inhibition < 50.0 % PMID[554175]
NPT441 Individual Protein Cytochrome P450 19A1 Homo sapiens Inhibition = 32.0 % PMID[554175]
NPT440 Individual Protein Quinone oxidoreductase Mus musculus Activity = 191.1 uM PMID[554175]
NPT2 Others Unspecified IC50 > 50000.0 nM PMID[554175]
NPT4880 Protein Family Cytochrome P450 1A Homo sapiens Inhibition = 40.0 % PMID[554175]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC175192 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9667 High Similarity NPC164427
0.9597 High Similarity NPC253904
0.9597 High Similarity NPC321363
0.953 High Similarity NPC207346
0.953 High Similarity NPC46564
0.9342 High Similarity NPC326910
0.9329 High Similarity NPC191634
0.9216 High Similarity NPC68727
0.9211 High Similarity NPC167903
0.9211 High Similarity NPC51824
0.9211 High Similarity NPC470337
0.9211 High Similarity NPC268992
0.9211 High Similarity NPC113608
0.9211 High Similarity NPC470338
0.9161 High Similarity NPC329091
0.9161 High Similarity NPC470339
0.9119 High Similarity NPC225419
0.9114 High Similarity NPC25361
0.9108 High Similarity NPC473961
0.9103 High Similarity NPC472055
0.9103 High Similarity NPC470810
0.9097 High Similarity NPC469584
0.9085 High Similarity NPC470340
0.9085 High Similarity NPC474843
0.9085 High Similarity NPC180944
0.9079 High Similarity NPC202595
0.9051 High Similarity NPC197168
0.9051 High Similarity NPC475985
0.9038 High Similarity NPC476242
0.9038 High Similarity NPC85121
0.9032 High Similarity NPC24640
0.9026 High Similarity NPC301233
0.902 High Similarity NPC470675
0.902 High Similarity NPC473131
0.9007 High Similarity NPC47388
0.9007 High Similarity NPC470670
0.9007 High Similarity NPC473133
0.9007 High Similarity NPC21835
0.9007 High Similarity NPC85773
0.9 High Similarity NPC6588
0.9 High Similarity NPC477154
0.9 High Similarity NPC474024
0.9 High Similarity NPC117854
0.8987 High Similarity NPC215612
0.8987 High Similarity NPC472964
0.8981 High Similarity NPC472902
0.8981 High Similarity NPC155302
0.8981 High Similarity NPC470183
0.8981 High Similarity NPC471976
0.8981 High Similarity NPC161947
0.8974 High Similarity NPC475267
0.8974 High Similarity NPC477833
0.8974 High Similarity NPC472910
0.8974 High Similarity NPC300727
0.8974 High Similarity NPC181960
0.8974 High Similarity NPC48208
0.8974 High Similarity NPC129684
0.8974 High Similarity NPC472913
0.8974 High Similarity NPC241904
0.8974 High Similarity NPC162869
0.8974 High Similarity NPC222814
0.8974 High Similarity NPC472914
0.8974 High Similarity NPC156057
0.8974 High Similarity NPC474208
0.8974 High Similarity NPC472911
0.8974 High Similarity NPC96167
0.8974 High Similarity NPC245758
0.8974 High Similarity NPC299520
0.8974 High Similarity NPC474836
0.8968 High Similarity NPC67396
0.8968 High Similarity NPC37392
0.8968 High Similarity NPC255807
0.8968 High Similarity NPC31018
0.8968 High Similarity NPC472909
0.8961 High Similarity NPC87708
0.8954 High Similarity NPC225854
0.8954 High Similarity NPC338131
0.8947 High Similarity NPC218569
0.8938 High Similarity NPC43319
0.8938 High Similarity NPC170245
0.8933 High Similarity NPC95751
0.8931 High Similarity NPC236132
0.8931 High Similarity NPC7483
0.8924 High Similarity NPC87431
0.8924 High Similarity NPC61010
0.8924 High Similarity NPC474186
0.8924 High Similarity NPC3629
0.8917 High Similarity NPC186113
0.8917 High Similarity NPC473990
0.8917 High Similarity NPC152904
0.891 High Similarity NPC235165
0.891 High Similarity NPC274730
0.891 High Similarity NPC201837
0.891 High Similarity NPC255106
0.8903 High Similarity NPC89474
0.8903 High Similarity NPC18727
0.8903 High Similarity NPC74924
0.8903 High Similarity NPC469405
0.8903 High Similarity NPC135522
0.8896 High Similarity NPC263384
0.8896 High Similarity NPC471676
0.8896 High Similarity NPC204515
0.8896 High Similarity NPC244577
0.8896 High Similarity NPC72958
0.8896 High Similarity NPC474021
0.8896 High Similarity NPC472420
0.8896 High Similarity NPC202157
0.8896 High Similarity NPC472422
0.8896 High Similarity NPC471229
0.8896 High Similarity NPC471677
0.8896 High Similarity NPC232645
0.8896 High Similarity NPC474023
0.8889 High Similarity NPC307052
0.8889 High Similarity NPC237440
0.8889 High Similarity NPC241874
0.8889 High Similarity NPC277032
0.8889 High Similarity NPC139966
0.8889 High Similarity NPC270160
0.8882 High Similarity NPC91902
0.8882 High Similarity NPC218226
0.8882 High Similarity NPC71055
0.8875 High Similarity NPC224280
0.8875 High Similarity NPC326520
0.8875 High Similarity NPC234052
0.8875 High Similarity NPC472049
0.8874 High Similarity NPC311144
0.8868 High Similarity NPC472402
0.8868 High Similarity NPC474162
0.8868 High Similarity NPC211107
0.8868 High Similarity NPC474150
0.8867 High Similarity NPC73028
0.8861 High Similarity NPC472630
0.8861 High Similarity NPC263449
0.8861 High Similarity NPC321399
0.8861 High Similarity NPC119224
0.8861 High Similarity NPC14353
0.8861 High Similarity NPC475886
0.8861 High Similarity NPC56085
0.8861 High Similarity NPC200746
0.8861 High Similarity NPC475784
0.8861 High Similarity NPC474287
0.8861 High Similarity NPC36217
0.8861 High Similarity NPC174953
0.8861 High Similarity NPC472631
0.8861 High Similarity NPC228785
0.8859 High Similarity NPC182421
0.8854 High Similarity NPC217677
0.8854 High Similarity NPC472598
0.8854 High Similarity NPC99597
0.8854 High Similarity NPC210084
0.8854 High Similarity NPC165977
0.8854 High Similarity NPC470402
0.8854 High Similarity NPC179732
0.8854 High Similarity NPC223787
0.8854 High Similarity NPC27337
0.8854 High Similarity NPC474055
0.8846 High Similarity NPC45849
0.8846 High Similarity NPC200761
0.8846 High Similarity NPC321779
0.8846 High Similarity NPC477503
0.8846 High Similarity NPC470327
0.8839 High Similarity NPC302950
0.8839 High Similarity NPC106976
0.8839 High Similarity NPC36835
0.8839 High Similarity NPC61506
0.8839 High Similarity NPC9743
0.8839 High Similarity NPC260491
0.8839 High Similarity NPC472912
0.8839 High Similarity NPC180234
0.8839 High Similarity NPC199100
0.8839 High Similarity NPC120537
0.8839 High Similarity NPC210597
0.8839 High Similarity NPC217149
0.8839 High Similarity NPC240476
0.8839 High Similarity NPC216035
0.8839 High Similarity NPC219582
0.8839 High Similarity NPC475790
0.8839 High Similarity NPC260979
0.8839 High Similarity NPC19721
0.8839 High Similarity NPC246162
0.8839 High Similarity NPC101996
0.8839 High Similarity NPC236637
0.8834 High Similarity NPC472620
0.8831 High Similarity NPC267117
0.8831 High Similarity NPC179183
0.8831 High Similarity NPC62042
0.8831 High Similarity NPC151473
0.8824 High Similarity NPC10097
0.8824 High Similarity NPC321011
0.8824 High Similarity NPC294852
0.8824 High Similarity NPC188679
0.882 High Similarity NPC469394
0.882 High Similarity NPC120593
0.882 High Similarity NPC37870
0.882 High Similarity NPC178851
0.882 High Similarity NPC272502
0.882 High Similarity NPC178173
0.8816 High Similarity NPC469758
0.8816 High Similarity NPC290133
0.8816 High Similarity NPC24136

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC175192 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8839 High Similarity NPD1934 Approved
0.8782 High Similarity NPD2393 Clinical (unspecified phase)
0.8662 High Similarity NPD2801 Approved
0.8533 High Similarity NPD1552 Clinical (unspecified phase)
0.8533 High Similarity NPD1550 Clinical (unspecified phase)
0.8528 High Similarity NPD6168 Clinical (unspecified phase)
0.8528 High Similarity NPD6166 Phase 2
0.8528 High Similarity NPD6167 Clinical (unspecified phase)
0.8477 Intermediate Similarity NPD1549 Phase 2
0.8471 Intermediate Similarity NPD4380 Phase 2
0.8457 Intermediate Similarity NPD6959 Discontinued
0.8442 Intermediate Similarity NPD1511 Approved
0.8395 Intermediate Similarity NPD5494 Approved
0.8385 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD6099 Approved
0.8344 Intermediate Similarity NPD6100 Approved
0.8333 Intermediate Similarity NPD1512 Approved
0.8323 Intermediate Similarity NPD7074 Phase 3
0.8323 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD3882 Suspended
0.8313 Intermediate Similarity NPD3818 Discontinued
0.8272 Intermediate Similarity NPD7075 Discontinued
0.8269 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8263 Intermediate Similarity NPD7054 Approved
0.8263 Intermediate Similarity NPD5844 Phase 1
0.8261 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8253 Intermediate Similarity NPD7473 Discontinued
0.8235 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8214 Intermediate Similarity NPD7472 Approved
0.8199 Intermediate Similarity NPD7819 Suspended
0.8199 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD6232 Discontinued
0.8176 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8166 Intermediate Similarity NPD6797 Phase 2
0.8158 Intermediate Similarity NPD1510 Phase 2
0.8153 Intermediate Similarity NPD2532 Approved
0.8153 Intermediate Similarity NPD2533 Approved
0.8153 Intermediate Similarity NPD2534 Approved
0.8148 Intermediate Similarity NPD5402 Approved
0.8148 Intermediate Similarity NPD3817 Phase 2
0.8146 Intermediate Similarity NPD1607 Approved
0.8125 Intermediate Similarity NPD6599 Discontinued
0.8118 Intermediate Similarity NPD7251 Discontinued
0.8118 Intermediate Similarity NPD6559 Discontinued
0.8105 Intermediate Similarity NPD2796 Approved
0.807 Intermediate Similarity NPD7808 Phase 3
0.8047 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD6801 Discontinued
0.8013 Intermediate Similarity NPD1240 Approved
0.8011 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD3751 Discontinued
0.7975 Intermediate Similarity NPD1465 Phase 2
0.7975 Intermediate Similarity NPD6799 Approved
0.7964 Intermediate Similarity NPD3787 Discontinued
0.7953 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7925 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD4628 Phase 3
0.7871 Intermediate Similarity NPD1551 Phase 2
0.7853 Intermediate Similarity NPD7411 Suspended
0.7834 Intermediate Similarity NPD2800 Approved
0.7831 Intermediate Similarity NPD3749 Approved
0.7826 Intermediate Similarity NPD5403 Approved
0.7816 Intermediate Similarity NPD8312 Approved
0.7816 Intermediate Similarity NPD8313 Approved
0.7806 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD8150 Discontinued
0.7784 Intermediate Similarity NPD8434 Phase 2
0.7778 Intermediate Similarity NPD1613 Approved
0.7778 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD3226 Approved
0.7707 Intermediate Similarity NPD2346 Discontinued
0.7705 Intermediate Similarity NPD6778 Approved
0.7705 Intermediate Similarity NPD6777 Approved
0.7705 Intermediate Similarity NPD6781 Approved
0.7705 Intermediate Similarity NPD6782 Approved
0.7705 Intermediate Similarity NPD6776 Approved
0.7705 Intermediate Similarity NPD6779 Approved
0.7705 Intermediate Similarity NPD6780 Approved
0.7702 Intermediate Similarity NPD5401 Approved
0.7702 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD3750 Approved
0.7662 Intermediate Similarity NPD943 Approved
0.7661 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD4749 Approved
0.7647 Intermediate Similarity NPD5710 Approved
0.7647 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD5711 Approved
0.7613 Intermediate Similarity NPD230 Phase 1
0.759 Intermediate Similarity NPD37 Approved
0.7588 Intermediate Similarity NPD1247 Approved
0.7581 Intermediate Similarity NPD7435 Discontinued
0.7574 Intermediate Similarity NPD6234 Discontinued
0.7566 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.756 Intermediate Similarity NPD7768 Phase 2
0.756 Intermediate Similarity NPD4967 Phase 2
0.756 Intermediate Similarity NPD4965 Approved
0.756 Intermediate Similarity NPD4966 Approved
0.7532 Intermediate Similarity NPD2935 Discontinued
0.7531 Intermediate Similarity NPD7390 Discontinued
0.7528 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD447 Suspended
0.75 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3926 Phase 2
0.7487 Intermediate Similarity NPD7698 Approved
0.7487 Intermediate Similarity NPD7697 Approved
0.7487 Intermediate Similarity NPD7696 Phase 3
0.7485 Intermediate Similarity NPD7199 Phase 2
0.7474 Intermediate Similarity NPD8151 Discontinued
0.7471 Intermediate Similarity NPD7228 Approved
0.7468 Intermediate Similarity NPD4625 Phase 3
0.7468 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD6651 Approved
0.7447 Intermediate Similarity NPD7870 Phase 2
0.7447 Intermediate Similarity NPD7871 Phase 2
0.744 Intermediate Similarity NPD5760 Phase 2
0.744 Intermediate Similarity NPD5761 Phase 2
0.7433 Intermediate Similarity NPD6823 Phase 2
0.7432 Intermediate Similarity NPD6534 Approved
0.7432 Intermediate Similarity NPD6535 Approved
0.7421 Intermediate Similarity NPD7701 Phase 2
0.7419 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4908 Phase 1
0.74 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD1610 Phase 2
0.7396 Intermediate Similarity NPD7801 Approved
0.7396 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD7783 Phase 2
0.7394 Intermediate Similarity NPD920 Approved
0.7391 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD2344 Approved
0.7368 Intermediate Similarity NPD919 Approved
0.7358 Intermediate Similarity NPD7033 Discontinued
0.7358 Intermediate Similarity NPD3748 Approved
0.7358 Intermediate Similarity NPD2799 Discontinued
0.7356 Intermediate Similarity NPD2403 Approved
0.7355 Intermediate Similarity NPD3027 Phase 3
0.7349 Intermediate Similarity NPD1653 Approved
0.7344 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7344 Intermediate Similarity NPD7874 Approved
0.7337 Intermediate Similarity NPD4363 Phase 3
0.7337 Intermediate Similarity NPD4360 Phase 2
0.7326 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD7699 Phase 2
0.7312 Intermediate Similarity NPD7700 Phase 2
0.7308 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD6190 Approved
0.7299 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD1243 Approved
0.7278 Intermediate Similarity NPD6844 Discontinued
0.7273 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7247 Intermediate Similarity NPD5953 Discontinued
0.7237 Intermediate Similarity NPD1608 Approved
0.7232 Intermediate Similarity NPD7286 Phase 2
0.7226 Intermediate Similarity NPD2861 Phase 2
0.7222 Intermediate Similarity NPD2424 Discontinued
0.7208 Intermediate Similarity NPD1470 Approved
0.7208 Intermediate Similarity NPD1203 Approved
0.7207 Intermediate Similarity NPD7685 Pre-registration
0.7197 Intermediate Similarity NPD2313 Discontinued
0.7197 Intermediate Similarity NPD3268 Approved
0.7197 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD411 Approved
0.7195 Intermediate Similarity NPD2309 Approved
0.7186 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD1652 Phase 2
0.7173 Intermediate Similarity NPD8319 Approved
0.7173 Intermediate Similarity NPD8320 Phase 1
0.7171 Intermediate Similarity NPD1201 Approved
0.717 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD5124 Phase 1
0.7161 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD2798 Approved
0.7152 Intermediate Similarity NPD3300 Phase 2
0.7152 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7229 Phase 3
0.7143 Intermediate Similarity NPD4308 Phase 3
0.7124 Intermediate Similarity NPD9717 Approved
0.7118 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD9494 Approved
0.7111 Intermediate Similarity NPD7240 Approved
0.7101 Intermediate Similarity NPD7458 Discontinued
0.7098 Intermediate Similarity NPD7584 Approved
0.7097 Intermediate Similarity NPD2797 Approved
0.7097 Intermediate Similarity NPD6212 Phase 3
0.7097 Intermediate Similarity NPD6213 Phase 3
0.7097 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD5353 Approved
0.7074 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD6674 Discontinued
0.707 Intermediate Similarity NPD6832 Phase 2
0.7069 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD6355 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data